Antineoplastic agents Olfaction disorders Signs and symptoms Taste disorders Few studies have described how patients receiving chemotherapy experience taste/ smell changes (TSCs). Food and meal situations have important meaning beyond nutrition, so these common symptoms may affect daily lives. This study aims to investigate distress and impact on daily life from TSCs in patients receiving cancer chemotherapy, analyze reported levels of distress and impact on daily life from TSCs with regard to sociodemographic and clinical factors, and explore patients' reports of self-care strategies and communication with staff. The 340 patients reporting TSCs on a multicenter survey (n = 518) were grouped into subsets by level of TSC-related distress and impact on daily life, which served as the basis for statistical comparison. Written comments were analyzed inductively using content analysis. Nearly one-third of participating patients reported both high levels of distress and impact on daily life (high distress and high impact on daily life [HDHI]) from TSCs. The HDHI subset reported other symptoms more often than others did (P = .01) and also more often responded to open questions about distress,
T aste and/or smell changes (TSCs) in patients with cancer can be related to a variety of causes, for example, progressive malignant disease, comorbidities, and treatment, including cytotoxic chemotherapy. Taste/ smell changes appear as complex subjective symptoms with both physical and psychosocial dimensions. 1, 2 Taste/smell changes can involve sensorial changes, originating in physical structures in the mouth (eg, damaged taste buds, mucositis, or dry mouth) or from neural pathways. 3 Taste/smell changes may also involve hedonic changes; that is, food can taste the same as usual, but that taste is no longer considered pleasant. 3 Several studies have tested Btrue taste[ acuity, 4Y6 but there is no consensus regarding direction of sensory thresholds or which tastes (salt, sweet, sour, or bitter) are most affected by chemotherapy.
Few studies have addressed how patients receiving chemotherapy experience TSCs or how these common symptoms affect daily life. The few existing studies indicate that TSCs can have an impact on patients' daily lives. 7Y9 These results are not surprising since food and meal situations have important symbolic, cultural, and religious values 2 beyond nutritional aspects and thus might be expected to affect psychosocial aspects of life. It is therefore important to assess not only the frequency and intensity of TSCs but also TSC-related distress and its impact on daily life to better understand and support the patient.
As Corner and Bailey 10 point out, conceptualization of symptoms has been dominated by a biomedical model, with successes achieved in cancer pain control using powerful drugs serving as an archetype. Corner and Bailey 10 argue that this biomedical construction may have resulted in the neglect of other aspects that may be equally important for care, such as suffering, distress, and ability to function independently. Such aspects are generally better addressed in nursing models. For example, Dodd et al 11 describe symptom experiences as a process whereby an individual perceives a symptom, evaluates its meaning, and then responds. This evaluation is proposed to include an assessment of not only severity, cause, and treatability but also the effect of the symptom on the person's life. 11 Richer and Ezer 12 complement the work of Dodd et al, 11 pointing to the importance of belief and meaning in assessing an individual's symptoms. They suggest that there are 2 levels of meaning, existential and situational, with the latter defined as Bthe person's perception of a new event and their capacity to handle it. [ 12(p1111) Richer and Ezer 12 describe how beliefs and existential meaning interact with experience and culture to shape situational meaning.
Nursing care for patients receiving cancer chemotherapy typically consists of interventions focused on preventing, minimizing, and alleviating treatment-related symptoms and problems and offering additional support to patients during the treatment phase. 10, 13 For adequate and appropriate nursing care to be provided, the existence of symptoms or problems must be communicated by the patient to the staff in some mannerVeither through routine assessment by staff or raised as a problem by patients. Verbal communication is an intrinsic part of contact between nurses and patients, and it is well recognized that the response of healthcare staff to patient concerns is of significance 14, 15 for how patients interpret their bodily signs. 13, 16 It has also been postulated that both staff and patients communicate less about symptoms that are believed to lack clear treatment alternatives. 17, 18 This may be particularly relevant in the case of TSCs, as our previous research indicated that patients may believe that TSCs are untreatable. 7 In an effort to be able to optimize care for patients with TSCs, we have carried out a series of studies investigating TSCs in patients receiving cancer chemotherapy. In a multicenter survey, 19 we found that 75% of 518 patients reported experiencing TSCs. These results are well in line with the prevalence of described chemotherapy-related TSCs in the literature. 19Y21 No substantial differences related to diagnosis or chemotherapy regimen were found. We did find that women and younger participants reported TSCs more often than others did. Participants reporting oral problems, nausea, appetite loss, and depressed mood also more frequently reported TSCs, although based on these data, we concluded that TSCs appeared to be more related to sociodemographic features than to clinical factors. This survey allowed us to recognize TSCs as a major symptom during chemotherapy but afforded little insight into its implications for patients.
The aims of the study presented here, based on the subset of the survey of participants reported TSCs, are therefore to (1) describe self-reported TSC-related distress and impact on daily life among patients receiving cancer treatment, (2) compare patients' reported levels of distress and impact on daily life from TSC with regard to sociodemographic characteristics and clinical factors, and (3) describe patient reports of self-care strategies, including communication with healthcare staff in relation to levels of distress and impact on daily life. n Methods As we found no Swedish questionnaire that addressed our research aims, we designed a study-specific survey to investigate TSCs among patients receiving cancer chemotherapy. The survey was developed by the research group based on findings from a previous qualitative interview study, 7 clinical experience, and existing literature. 8, 22 It contained 33 questions, with both open-ended and closed response alternatives. The survey began with questions about background data, that is, sociodemographic and clinical characteristics, including occurrence of other potential chemotherapy-related symptoms (nausea, vomiting, oral problems, depressed mood, and weight change, assessed by 5 response alternatives from never to always, as well as space for comments). This section ended with an open question about other problems that the participants believed to be related to chemotherapy. The following section focused on taste changes and appetite (7 questions), followed by a similar section on smell changes (8 questions) , with examples of questions shown in Table  1 . The next 3 questions assessed sources of information about TSCs, as well as communication about TSCs between patients and healthcare providers. The final 2 questions were open ended, encouraging patients to provide additional relevant information and to comment on the survey itself. Information about cancer diagnosis, present chemotherapy regimen, number of chemotherapy cycles, previous chemotherapy regimens, and medications given in conjunction with chemotherapy was obtained from medical records.
An initial draft of the survey was reviewed by experienced chemotherapy nurses and by a group of cancer care researchers.
The draft was then pilot tested in a group of adult patients receiving chemotherapy selected for heterogeneity, including women and men with a wide range of ages and degrees of TSCs. A think-aloud method 23Y25 was used to ensure that items were understandable and that the respondent interpreted the questions as intended. After 3 think-aloud interviews, the survey was revised. Seven additional think-aloud interviews were held without necessitating further revision. As a final control, 3 additional patients completed the survey alone, with the researcher then checking that analysis and interpretation were in line with the patients' intended responses. The study protocol was approved by the Regional Research Ethics Review Board in Stockholm (2005/77-31/3).
Sample
This cross-sectional survey was distributed to a consecutive sample of adult cancer patients receiving chemotherapy at 11 oncology and gynecology outpatient units in 3 of the 6 healthcare regions in Sweden. Patients eligible for inclusion had received chemotherapy for more than or equal to 6 weeks, were able to read and write in Swedish, had no disabilities or problems that contraindicated participation, and gave informed consent.
A total of 675 patients were eligible for inclusion. Ninetytwo participants declined participation, and 61 did not participate because of administrative errors. Four survey questionnaires lacked sufficient data for analysis. The final database thus consisted of 518 participants who completed the survey once, usually in hospital. Approximately 20 participants did not complete the survey immediately on site but instead returned it by mail or at next hospital contact.
This article is based on an analysis of data from the 340 participants who self-reported taste changes, with 214 of these also reporting smell changes in conjunction with taste changes.
Operationalization of TSC-Related Distress and Impact on Daily Life
Subsets of participants were first determined based on reported level of TSC-related distress, impact on daily life, and strategies as described below. In the survey, we asked separately about taste and smell. However, participants' responses to these open-ended questions were not always well differentiated, with responses often combining issues of taste and smell. Because there is also evidence that these senses interact, 27, 28 we combined responses from questions about distress from taste ( smell questions, the highest response alternative was used in these new variables (n = 53, regarding distress; n = 46, regarding impact on daily life of 340 participants The sample was than divided into 4 subsets based on level of TSC-related distress and impact on daily life to explore potential differences between groups. The subsets consisted of participants reporting the following: 
Data Analysis
Inductive analysis (AIMS 1 and 3): comments in response to open-ended questions about TSC-related distress and impact on daily life and strategies used to alleviate TSCs (Table 1 , questions 18c, 26c, 19b, and 27b) were analyzed inductively using content analysis. 26 Statements were coded by the first author using NVivo software (QSR International Pty Ltd, Australia, www.qsrinternational.com). This process led to 88 codes, which were initially organized into 9 discrete categories. These categorizations were repeatedly discussed by the research group to differentiate content and definition, and recategorizations of random selections of data were tested repeatedly by independent coders. The coding scheme was finalized, with all responses grouped into 8 categories, of which 4 were related to TSCrelated distress and impact on daily life and 4 related to strategies used to deal with TSCs. The final Cohen . for interrater agreement was 0.92.
Statistical analysis (AIMS 1, 2, and 3): differences in proportions between subsets were analyzed with # 2 tests, using a significance level of 0.05 for all analyses.
n Results
Distress and Impact on Daily Life From TSCs (AIM 1)
Half the 340 participants with TSCs reported high distress from them, and nearly one-third reported HDHI from TSCs ( Table 2) . Data from the 3 participants who reported low distress but high impact on daily life have not been further analyzed statistically.
A total of 128 of the 340 participants (40%) responded to open-ended questions ( Table 1 , questions 19b and 27b) about TSC-related distress and impact on daily life. The 4 categories concerning TSC-related distress and impact on daily life are presented in Table 3 . There were significantly more responses to these questions from participants in the HDHI subset than those in HDLI or LDLI subsets (P G .01).
Statements regarding TSC-related distress and impact on daily life were formulated into 4 categories. Codes included in 2 of the categoriesVpsychosocial aspects versus somatic aspectsV appear to be along a continuum rather than in a dichotomous relationship (Table 3 ). In the psychosocial category, we have coded descriptions of feelings related to TSCs (n = 66), such as and Bappetite loss[ (n =17) were categorized as somatic aspects although the latter code could include somewhat diffuse statements indicating lack of desire for food, for example, BI know I have to eat, but at the same time I have no urge to. [ The third category, BDifficulties related to food and eating,[ consists of statements related to descriptions about characteristics of taste changes (n = 51) and how they impact on daily life, for example, inability to participate in socialrelated situations like sharing a meal or need for own food (n = 6). Some responses regarded difficulties in preparing food they cannot taste properly (n = 16). This category also includes statements about food selection (n = 8) that previously had been routine and sometimes unconscious behavior but now demanded more conscious thought, for example, Bhave to think a lot about food preparation. [ In the fourth category, BDifficulties related to sense of smell,[ we include statements related to descriptions of smell changes (n = 36) due to either decreased sensitivity (n = 8) or increased sensitivity (n = 20), for example, Buncertain if I smell badly, it's embarrassing to acknowledge for others that I don't recognize smells.[ Most of these statements related to a hypersensitivity to smoke, one's own body odor or that of others, cooking odors, and perfumes. These statements also describe effects on social life, for example, Byou're disturbed by strong perfumes and such in public places[ and Bcan't go near anyone during the first six days I /after chemotherapy/.[ It is important to recognize that problems were seldom described in isolation but as having clear causal relationships, which affect both perception of TSC-related distress and impact. This quote from one participant in the HDHI subset illustrates both the multitude of problems arising and their interactions:
Brings me down, there's a bit of nausea from the awful taste in my mouth, eating is no fun since I have no desire, can't think or plan or prepare food, which means that I skip meals, and then I feel sick to my stomach and tiredVand then sad. Table 2 presents sociodemographic and clinical characteristics of patients by subsets. Those participants who reported HDHI were more often women (P G .05), living in household with children below 18 years (P G .01), and more often diagnosed with breast cancer (P G .01) compared to those participants who reported LDLI. Participants who reported LDLI more often lived with adults only (P G .01) compared to those in HDHI subsets. Participants in LDLI and HDLI subsets had lower levels of education (P G .01) and were more often treated with fluorouracil, folinic acid, and oxaliplatin (P G .01) compared to those in the HDHI subset. Participants who reported HDHI from TSCs (Figure 1 ) more often also reported nausea (P G .01), vomiting (P G .01), oral problems (P = .01), depressed mood (P G .01), and/ or appetite loss (P G .01). A statistically significant difference between all 3 subsets was found in relation to appetite loss (P G .05), with participants in HDHI most often and in LDLI least often reporting this symptom. We also found that depressed mood is significantly more common in the HDLI subset (P = .01) than in participants in the LDLI subset. In this sample, no significant differences were found among subsets with regard to reported weight changes.
Comparing Subsets by Sociodemographic Characteristics and Clinical Factors (AIM 2)

Strategies for Dealing With TSCs (AIM 3)
One hundred ninety-eight of the 340 participants (57%) responded to open-ended questions ( Table 1 , questions 18c and 26c) about strategies used to deal with TSCs. The 4 categories related to strategies are shown in Table 3 . These strategies share a focus on more or less actively avoiding unpleasant TSC-related experiences. Few statements referred explicitly to strategies focusing on emotional effects of TSCs, although strategies more frequently addressed social effects.
The category Bstrategies related to food and eating[ includes reports of how to avoid or choose specific foods or seasonings. The open comments contained more than 50 references to different foods and beverages; among the most common comments were reports that fruit was readily eaten (n = 9) and complaints about the changed taste of water (n = 10) and coffee (n = 7). Sweet tastes were avoided by 8 participants, whereas 3 chose to eat sweet products more often. Of the 12 participants referring to the salty tastes, half reported a preference for salt, whereas the other 6 avoided salt. Some participants changed their routines in serving food (n = 5), for example, they ate only cold food or set the table differently, whereas others found it important to keep familiar routines. Asking for help in cooking (n = 9) or seasoning food was also a common strategy. Making use of taste and smell memories (n = 3) was described as helpful by a few: BI sniff down close to the food, and look at it, and think about how it should taste. [ BStrategies focusing on the mouth[ include efforts directed locally to the oral cavity, for example, oral hygiene (n = 23), chewing gum (n = 16), or frequently sucking on lozenges (n = 7). Some participants reported using medication to alleviate mucositis (n = 4). The category labeled avoiding odors includes avoiding smoke (n = 8), car exhaust (n = 4), body odors (n = 11), and/ or public places (n = 11), for example, BI try to avoid places where people smoke and have strong perfumes, which isn't always easyVfor example on trains.[ This category includes strategies describing increased cleanliness (n = 33) to avoid unpleasant odors, for example, more frequent cleaning, airing rooms, and washing clothing, as well as more frequent personal hygiene: Bthrow clothes in the laundry more often, clean the fridge, run the dishwasher more often. An open question as to whether the strategy reported was found helpful was responded to by approximately 50% of the respondents, with about half the reported strategies described as helpful, as shown in Table 4 . Although many strategies were said not to alleviate TSCs per se, they could instead facilitate coping with TSC-related impact and distress. Statements categorized under avoiding odors were most often reported as useful, whereas strategies focusing on the mouth were reported to be least helpful ( Table 4 ).
Communication of TSCs Between Participants and Staff (AIM 3)
A total of 271 of the 330 participants (82%) who responded to questions about information on TSCs reported that they had been informed that TSCs could occur during chemotherapy, 8% reported receiving no information, and 10% did not remember. Nearly 12% of those reporting having accessed information about TSCs did so from sources other than the healthcare staff. Table 5 presents reported informa-tion sources by participant subset, showing no statistically significant differences among subsets.
Three hundred six participants responded to a question asking if they notified healthcare staff about their TSCs, with 29% reporting not having informed the staff. Eighteen percent of these reported high distress and high impact on daily life, which was not communicated to the staff (Table 6) . Younger participants (P G .05) more often reported telling the staff about their TSCs than older participants did, with no differences found between sexes.
n Discussion
This study was based on a survey of TSCs in 518 patients receiving cancer chemotherapy, focusing on the 340 participants who self-reported taste changes. Most of these participants (n = 214) also reported smell changes. Nearly one-third of those with TSCs reported experiencing high levels of both distress and impact on daily life (HDHI) from them. These participants also reported experiencing other symptoms more often than those participants who were not in the HDHI subset did; despite this, they did not always inform the healthcare staff about their TSCs. We also found that despite the high prevalence of distress and impact on daily life related to psychological aspects of TSCs, few participants reported strategies specifically directed at alleviating such problems.
It should be recognized that the design of this survey excluded the Bsickest[ and most vulnerable patients, for example, those receiving treatment with long infusion times and those requiring more surveillance than is possible in outpatient care. However, it is reasonable to assume that this sample reflects the outpatient chemotherapy population in Swedish oncology and gynecology departments. The design of the study made it possible to reach a broad sample of patients who were undergoing different chemotherapy regimens; even so, there were few statements in some of the categories of some subsets. One potential limitation is that recruitment via these departments contributed to the relatively large proportion of women in this sample, which should be remembered when considering the gender differences found. On the other hand, the mixed method design has enriched this study by adding substance to statistics. Investigation by subset allowed us to distinguish the importance of examining impact on daily life, in addition to distress.
Through inductive analysis of open comments, we hoped to see if there were differences in how distress, impact on daily life, and strategies for dealing with TSCs were described in the 3 subsets (HDHI, HDLI, and LDLI), but the limited number of statements in the LDLI and HDLI subsets prevents drawing reliable conclusions. However, we did find that the number of statements proffered about distress and impact on daily life on each topic differed significantly between the HDHI subsets and the others, with the greatest differences regarding psychosocial aspects. Whether participants responded to open-ended questions seemed not to be directly related to the degree of distress reported from TSCs alone; TSC-related impact on daily life seems to be a key attribute in these participants' experiences.
We propose that the investigation on the combination of distress and impact on daily life should provide an indirect indicator of the situational meaning 12 of TSCs for these participants.
Haworth and Dluhy 14(p305) motivate the importance of meaning of symptoms in that it often Bprovides the driving force to initiate the health encounter.[ In our data, communication with healthcare staff seems to have a more complex relationship with meaning, as TSCs were not always communicated by patients to the staff, not even by those reporting both high TSC-related distress and impact on daily life. One possible explanation suggested by these findings as well as our previous work 7 may be that some participants have difficulties envisioning TSCs as Btreatable,[ 11 which may lead them not to communicate these symptoms to the staff. Goodman et al 18 also state that taste changes are rarely reported spontaneously, although the empirical basis for this comment is unclear. Haworth and Dluhy 14 point out that patients may present limited information about a symptom for a number of other reasons, for example, thinking that their experience is trivial, lack of time, or assuming the staff will discover the symptom on their own during physical examination. They also note that people might have difficulties articulating their problems, 14 which we also found to be the case in a prior qualitative interview study with patients with TSCs. 7 The interviewed participants had difficulties expressing their experiences of TSCs due to lack of recognition of the symptom and lack of words to describe their sensations. This may provide yet another explanation as to why TSCs are undercommunicated to healthcare staff.
In an earlier work, we found significant relationships between reports of TSCs and oral problems, appetite loss, nausea, and depressed mood. In this study, we found that compared with the LDLI and HDLI subsets, those participants reporting high degrees of distress and impact on daily life also significantly more often reported these symptoms, as well as vomiting. Honea et al 29 investigated treatment-related symptom clusters and found that when chemotherapy stimulates chemoreceptor trigger zones, it causes nausea and vomiting, which in turn has been associated with poor appetite, altered taste, and fatigue. This raises the question as to whether our findings may suggest the existence of a symptom cluster.
Taste and smell changes have also been found to lead to secondary anorexia, 30 with Hutton et al 1 finding that TSCs are associated with weight loss in patients with advanced cancer, although chemotherapy recipients were excluded from their study. In an earlier analysis of our survey, 19 we found that approximately one-third of the 518 participants reported weight loss, whereas one-third reported weight gain. No weight-related differences were found among the subsets examined in this study. Wickham et al 8 also found that weight loss was not related to TSCs in their study of patients on cancer chemotherapy, concluding that taste changes were more likely to originate from chemotherapy rather than from a progressive cancer disease.
In the full sample of 518 patients, 19 we found that women more often reported TSCs; in this further analysis of the sample with TSCs, we also found that degree of distress and impact on daily life varied by sex, with women reporting more distress and greater impact on daily life from TSCs. The reasons for gender differences in reports of symptoms are controversial, with little consensus found in the literature (compare the studies by van Wijk and Kolk 31 and Macintyre et al 32 ) as to whether such findings are due to women more readily reporting problems or to differences in prevalence or perception of TSCs and other symptoms. In this study, we tested a large number of hypotheses, which entails a risk of type 1 statistical errors. The reported results should be judged against this background. However, because of the exploratory nature of the study, we felt that this approach was reasonable as opposed to using statistical techniques to adjust the observed P values for the multiple comparisons. Our investigations on differences among subsets in number and content of statements in response to open questions are dependent on the stringency and reliability of the categorization of their manifest content. Through a stringent process of discussion and clarification of categorization and coding schemes, we achieved a high level of intercoder agreement in this material.
Another methodological consideration relates to the optimal time point for investigating chemotherapy-related TSCs, which might be when TSCs peak. This time point is not easy to establish, as it differs between individuals, 7 with one-third of participants in our survey reporting continual TSCs during the entire treatment regimen. 19 The design used here means that some participants may have responded retrospectively, whereas others may respond while experiencing TSCs. We assume that we have not surveyed all patients at the peak of their TSCs. This may mean that the nearly one-third of those participants reporting HDHI may be an underestimation of this problem due to recall bias. These results make it evident that chemotherapy-related TSCs are of major concern. n Implications This sample described a variety of practical means of dealing with and alleviating TSCs, although these reports suggest that there is no golden standard used. It therefore seems important that nurses provide active support for patients' own self-care, acting as discussion partners, helping them evaluate different strategies, and encouraging innovative efforts to diminish distress and impact on daily life. The results of this study also highlight the importance of situational meaning based on patient's interpretations. This underscores the need to include patients' living situation, history, beliefs, situational meaning, and priorities in a thorough initial nursing assessment.
These results indicate a close relationship between TSCs and other adverse effects (nausea, vomiting, depressed mood, appetite loss, and oral problem), which raises the question of how these symptoms interact. It would be beneficial to focus additional research on patients' entire symptom panorama during chemotherapy rather then focusing solely on single adverse effects. This could involve investigation of symptom interactions as well as social and psychological factors that could impact on patients' perceived meaning of the situation.
